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Reply 
We thank Dr. Title for his interest in our article. As we 
mentioned in the discussion of the paper, we believe that 
the endothelial impairment can be seen by the fact that the 
postischemic brachial artery diameter failed to increase 
after glucose load despite an increased blood velocity dur-
ing reactive hyperemia. This failure of dilation resulted in 
a higher velocity to diameter ratio, a surrogate measure-
ment of shear stress. This was further confirmed by 
excluding the possibility that the maximal ability of the 
vessel to dilate was reached. Thus, it was showed that the 
vessel diameter was further increased in response to sub-
lingual administration of nitroglycerine. 
In addition, further support that our conclusions are 
correct comes from the fact that similar results to our work 
were also reported in another recently published study that 
used completely different methodology.l Furthermore, it 
should be mentioned that a trend towards increased base-
line brachial arteries has been reported in patients with dia-
betes and in women who are postmenopausal and not 
undergoing hormone replacement therapy.2,3 The reason 
for these findings is not known, but it is probably related 
to the fact that the baseline vessel measurement is inverse-
ly related to flow-mediated vasodilation, as mentioned by 
Dr Title. 
Regarding the microcirculation, acetylcholine tradi-
tionally has been considered as causing endothelium-
dependent vasodilation in both the microcirculation and 
macrocirculation.4 The recent suggestion that the response 
to acetylcholine is likely mediated by prostanoids needs fur-
ther investigation. However, because aspirin has been 
shown to have no effect for the flow-mediated large artery 
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dilatation yet inhibition of the production of nitric oxide 
does (through the intra-arterial injection OfL-NMMA), it 
seems difficult to comprehend a completely different 
mechanism for the microcirculation. Furthermore, because 
L-NMMA is a weak inhibitor of nitric oxide production, 
studies that will use L-NAME, a stronger inhibitor, may be 
necessary before definite conclusions are reached.5 
Aristidis Veves, MD 
Beth Israel Deaconess Medical Center 
Boston, Mass 
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